Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents.

Saved in:
Bibliographic Details
Title: Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents.
Authors: Sun Z; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Jaswal AP; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Chu X; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Rajkumar H; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Cortez AG; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Edinger R; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Rose M; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Josefsson A; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States.; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Bhise A; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States.; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Huang Z; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Ishima R; Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Mellors JW; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Dimitrov DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Li W; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States., Nedrow JR; Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States.; Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, United States.
Source: ACS omega [ACS Omega] 2023 Nov 08; Vol. 8 (46), pp. 43586-43595. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101691658 Publication Model: eCollection Cited Medium: Internet ISSN: 2470-1343 (Electronic) Linking ISSN: 24701343 NLM ISO Abbreviation: ACS Omega Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2470-1343
DOI:10.1021/acsomega.3c04492